FDA Warning Letter — Reliance Life Sciences Private Limited
The FDA took a Warning Letter action against Reliance Life Sciences Private Limited on Aug 18, 2026 (Navi Mumbai, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Reliance Life Sciences Private Limited
- Date
- Aug 18, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Navi Mumbai (India)